News
ICPI WEEK 2025, a comprehensive event bringing together component and materials companies across pharmaceuticals, biotech, ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter ...
BNCM and DELEX Pharma are proud to announce that DELEX has been officially appointed as the Spot Dealer for the newly ...
EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...
Hyundai Motor said on Thursday it has launched a task force to respond to U.S. tariffs and reaffirmed its annual earnings ...
16h
Korea JoongAng Daily on MSNKospi closes lower as investors await result of tariff talksShares finished a tad lower Thursday as investors awaited tariff talks with the United States amid deepening concerns over ...
SEOUL, April 24 (Yonhap) -- South Korean stocks finished a tad lower Thursday as investors awaited tariff talks with the ...
IDIS, the largest in-country manufacturer of trusted South Korean-made video tech, now offers an extensive and versatile ...
6hon MSN
"The whole situation is a bit like lockdowns," tweeted Molson Hart, chief executive of Viahart, a toy manufacturer with operations in China. "Once you shut down, it takes a long time to get economic ...
3d
Zacks Investment Research on MSNJAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?Jazz Pharmaceuticals JAZZ and Harmony Biosciences HRMY have emerged as notable players in the neuroscience space, especially in the sleep disorder segment. Jazz Pharmaceuticals markets multiple ...
European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results